Td Private Client Wealth LLC Grifols Sa Transaction History

Td Private Client Wealth LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Aug 16, 2024	SELL	$10.21 - $15.27 $1,368 - $2,046	-134 Closed	0 $0
Q3 2021 Aug 16, 2024	BUY	$14.07 - $17.3 $1,885 - $2,318	134 New	134 $1.96 Million
Q1 2021 Aug 16, 2024	BUY	$15.15 - $19.78 $1,515 - $1,978	100 Added 294.12%	134 $2.32 Million
Q1 2020 Aug 16, 2024	SELL	$16.28 - $25.63 $26,959 - $42,443	-1,656 Reduced 97.99%	34 $685,000
Q4 2019 Aug 16, 2024	BUY	$19.57 - $23.52 $33,073 - $39,748	1,690 New	1,690 $39.4 Million

164

140M

288K

389K

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $5.33B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

Get notified when there are updates to the investment portfolio of Td Private Client Wealth LLC, based on Form 13F filings with the SEC.

Stay updated on Td Private Client Wealth LLC with notifications on news.